207_Combined course Presentations
3) Ongoing study on the role of altered fractionation: the CONVERT trial
Phase III randomized trial
447 patients enrolled, accrual closed, results expected very soon.
The results will be crucial in determining the best standard regimen for LD-SCLC Higher dose of radiation in the “once-daily” arm, compared to the hyperfractionated one (66 Gy vs 45)
Primary endpoint: OS
Faivre-Finn C. et al. BMJ 2016;6
Made with FlippingBook